Basit öğe kaydını göster

dc.contributor.authorAlekseeva, Lyudmila
dc.contributor.authorMigliore, Alberto
dc.contributor.authorBannuru, Raveendhara R.
dc.contributor.authorBlicharski, Tomasz
dc.contributor.authorDiracoglu, Demirhan
dc.contributor.authorGeorgiadis, Athanasios
dc.contributor.authorHamoud, Hesham
dc.contributor.authorMartusevich, Natalia
dc.contributor.authorCerinic, Marco Matucci
dc.contributor.authorPerduk, Jan
dc.contributor.authorSzerb, Imre
dc.contributor.authorTrc, Tomag
dc.contributor.authorChevalier, Xavier
dc.contributor.authorGigliucci, Gianfranco
dc.date.accessioned2022-02-18T09:52:56Z
dc.date.available2022-02-18T09:52:56Z
dc.identifier.citationMigliore A., Gigliucci G., Alekseeva L., Bannuru R. R. , Blicharski T., Diracoglu D., Georgiadis A., Hamoud H., Martusevich N., Cerinic M. M. , et al., "Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis", ORTHOPEDIC RESEARCH AND REVIEWS, cilt.13, ss.255-273, 2021
dc.identifier.otherav_6742a713-590c-4f9e-a299-9ea5787f3358
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/178158
dc.identifier.urihttps://doi.org/10.2147/orr.s336185
dc.description.abstractOsteoarthritis (OA) is a significant cause of disability. Considering the increasing diffusion of the viscosupplementation (VS) with hyaluronic acid (HA), the International Symposium Intra Articular Treatment (ISIAT) appointed a Technical Expert Panel (TEP) to identify the criteria for successful VS with a specific HA in OA; this through a systematic literature review (SLR), performed following the PRISMA guidelines interrogating Medline, Embase, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Grey Matters and American College of Rheumatology (ACR/EULAR) databases and the opinion of international experts. The research included only studies on adults and humans without limitations of language or time of publication. Researchers extracted both quantitative and qualitative data from each study. Mixed Methods Appraisal Tool (MMAT) was used to perform quality analysis for the level of evidence. The SLR retrieved 385 papers, 25 of which were suitable for the analysis. The TEP focused on the different formulations of the product Sinovial (R) [HA 0.8%, HA 1.6%, HA 2%, 800-1200 kDa, HA 3.2% (1400-2100 kDa/65-110 kDa)]. The choice was due to the vast amount of evidence available. The TEP weighed the evidence in two rounds of a Delphi survey; the results, and any disagreement, were discussed in a final session. Three domains were considered: 1) the patients' characteristics associated with the best results; 2) the contraindications and the conditions linked to increased risk of failure; 3) the clinical conditions in which VS is considered appropriate. The TEP concluded that VS with HA is safe and effective in the treatment of knee and hip OA of grades I to III and that it is possible to undertake VS in other situations (eg grade IV Kellgren-Lawrence - KL); a comprehensive examination of the patient should be performed before the procedure.
dc.language.isoeng
dc.subjectOrthopedics and Sports Medicine
dc.subjectORTOPEDİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectOrtopedi ve Travmatoloji
dc.subjectPodiatry
dc.subjectHealth Sciences
dc.titleSystematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis
dc.typeMakale
dc.relation.journalORTHOPEDIC RESEARCH AND REVIEWS
dc.contributor.departmentSan Pietro Fatebenefratelli Hosp , ,
dc.identifier.volume13
dc.identifier.startpage255
dc.identifier.endpage273
dc.contributor.firstauthorID2774133


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster